Listen as Leslie Citrome, MD, MPH, and Adam Lowy, MD, share information on long-acting injectable antipsychotics ranging from pharmacokinetic properties to strategies on incorporating these agents into clinical practice.
In this podcast episode, Leslie Citrome, MD, MPH, and Adam Lowy, MD, share a wealth of knowledge about long-acting injectable (LAI) antipsychotics. Their conversation begins with an overview of the pharmacokinetic profiles of LAI antipsychotics and how they differ from their oral counterparts, as well as injection intervals available with current formulations. The experts also discuss the clinical utility of LAI antipsychotics in psychiatry practice, highlighting their role in assuring medication adherence and their application in both first- and later-episode psychosis. Finally, Drs Citrome and Lowy hit on practical aspects of incorporating LAI antipsychotics into patient care: communicating with patients to dispel myths and stigma surrounding injectable medications, identifying injection resources in your medical community, and strategies to navigate insurance barriers.
Throughout the podcast, Drs Citrome and Lowy reference several links to outside sources that can provide valuable education on LAI antipsychotics. Those links are listed below for your convenience.
Administering LAI Into Dorsal Gluteal Site:
https://bit.ly/3XjSm5a
Administering LAI Into Deltoid Site:
https://bit.ly/3Xlyq1L
Administering LAI Into Abdominal Site:
https://bit.ly/3wgGJ2Z
Presenters:
Leslie Citrome, MD, MPH
Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York
Adam Lowy, MD
Staff Psychiatrist
Ellenhorn
Los Angeles, California
This activity is supported by educational funding provided byOtsuka America Pharmaceutical, Inc. and Lundbeck.
For additional activities in this program, visit:
https://bit.ly/3iM0HiP